For 18 years, Truffle Capital has been creating and financing to success radical and disruptive innovations in two fields of expertise, Life Sciences and Information Technologies. These creations revolutionize their sectors and will become the tomorrow’s leaders.
Truffle Capital is the only European Fund to support its innovations from creation to commercial success.
Truffle Capital works closely with the world's best 50 universities to select and transform their most significant inventions into major technological innovations, novel medical devices and effective drug treatments.
In terms of Information technologies, Truffle Capital has focused in FinTechs since 2014. Thanks to its team of dedicated experts, Truffle is able to select products & services with underlying complex technologies (deep tech).
Truffle Capital collects €390m across two venture funds
French venture firm Truffle Capital has closed its BioMedTech fund on €250m and Fintech-Insurtech vehicle on €140m...
Truffle Capital a levé 390 millions pour deux nouveaux fonds
Les nouveaux véhicules seront consacrés aux medtechs (250 millions d'euros) et aux fintechs (140 millions d'euros).
Truffle Capital Raises €250M Fund to Launch Life Science Startups
The French VC firm Truffle Capital has closed a fund worth €250M with a mission to nurture companies specializing in medical devices